Fortress Biotech, Inc.
FBIO, FBIOP · Pharmaceutical Preparations · 82.5M shares · -37%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: -$33M (gross $70K, SBC $33M)
Reference price $1.29 · est. market cap ~$106M — last insider sale, 2025-05-29 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D50Biopharma holding company (multiple subsidiaries) — operating losses; net income one-off/subsidiary-gain-driven.
Strengths
- Diversified subsidiary portfolio and some revenue — per 10-K
Risks
- Operating losses, complex structure — operating margin -111%, net income -115%
- Leverage — D/E 1.1 (82nd)
- Subsidiary-funding/dilution risk — per 10-K
Notable findings
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Buying back stockNet buyback — share count -37%/yr over 3y
- Notable holderHeld by 4 notable fund(s): CITADEL ADVISORS LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC +1 more (as of 2026-03-31)
- New fund positionNotable fund(s) opened this quarter: FMR LLC
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
66.9%
Operating margin
-111.0%
Net margin
10.8%
Return on equity
13.7%
Return on assets
3.7%
ROIC
-54.2%
Revenue growth (QoQ)
-0.3%
Debt / equity
1.1×
Current ratio
2.5×
Tangible book value
$22M
Cash & investments
$79M
Stock comp / revenue
45.4%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-22 | Jin David | Grant | 400K | — |
| 2026-04-01 | Jin David | Grant | 3.0K | $2.18 |
| 2026-03-18 | WEISS MICHAEL S | Grant | 475K | — |
| 2026-03-18 | ROSENWALD LINDSAY A MD | Grant | 475K | — |
| 2026-01-02 | Fortress Biotech, Inc. | Grant | 278K | — |
| 2026-01-01 | Klein Dov | Grant | 27K | — |
| 2026-01-01 | Harvey Jimmie | Grant | 27K | — |
| 2026-01-01 | Hoenlein Malcolm | Grant | 27K | — |
| 2026-01-01 | LOBELL J JAY | Grant | 27K | — |
| 2026-01-01 | Lorenz Kevin | Grant | 27K | — |
| 2025-10-01 | Jin David | Grant | 2.7K | $1.31 |
| 2025-09-29 | Fortress Biotech, Inc. | Grant | 59K | — |
| 2025-05-30 | Fortress Biotech, Inc. | Disposition | 6.1M | $4.10 |
| 2025-05-29 | Fortress Biotech, Inc. | Sell | 100K | $1.29 |
| 2025-04-01 | Jin David | Grant | 5.0K | $1.22 |
| 2025-03-31 | Fortress Biotech, Inc. | Grant | 68K | — |
| 2025-02-26 | Fortress Biotech, Inc. | Grant | 18K | — |
| 2025-01-01 | Harvey Jimmie | Grant | 49K | — |
| 2025-01-01 | Lorenz Kevin | Grant | 49K | — |
| 2025-01-01 | Hoenlein Malcolm | Grant | 49K | — |
| 2025-01-01 | Fortress Biotech, Inc. | Grant | 2.4M | — |
| 2025-01-01 | WEISS MICHAEL S | Grant | 454K | — |
| 2025-01-01 | ROSENWALD LINDSAY A MD | Grant | 454K | — |
| 2025-01-01 | LOBELL J JAY | Grant | 49K | — |
| 2025-01-01 | Klein Dov | Grant | 49K | — |
| 2025-01-01 | Lu Lucy | Grant | 49K | — |
| 2024-12-31 | Fortress Biotech, Inc. | Grant | 81K | — |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-23 | Shareholder vote | filing ↗ |
| 2026-05-14 | ResultsExhibits | filing ↗ |
| 2026-03-31 | ResultsExhibits | filing ↗ |
| 2026-03-30 | OtherExhibits | filing ↗ |
| 2026-02-23 | Material agreementDebt obligationOtherExhibits | filing ↗ |
| 2026-01-13 | OtherExhibits | filing ↗ |
| 2025-12-15 | OtherExhibits | filing ↗ |
| 2025-12-15 | Material agreementDebt obligation3.02 | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-23 | 2026-06-17 | 0001104659-26-076811 ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | 0001104659-26-061233 ↗ |
| 8-K | 2026-05-14 | 2026-05-14 | 0001104659-26-061208 ↗ |
| 10-K | 2026-03-31 | 2025-12-31 | 0001104659-26-037874 ↗ |
| 8-K | 2026-03-31 | 2026-03-31 | 0001104659-26-037749 ↗ |
| 8-K | 2026-03-30 | 2026-03-30 | 0001104659-26-036818 ↗ |
| 8-K | 2026-02-23 | 2026-02-22 | 0001104659-26-018371 ↗ |
| 8-K | 2026-01-13 | 2026-01-13 | 0001104659-26-003121 ↗ |
| 8-K | 2025-12-15 | 2025-12-15 | 0001104659-25-120893 ↗ |
| 8-K | 2025-12-15 | 2025-12-12 | 0001104659-25-121187 ↗ |
| 8-K | 2025-11-17 | 2025-11-14 | 0001104659-25-112945 ↗ |
| 10-Q | 2025-11-14 | 2025-09-30 | 0001104659-25-111989 ↗ |